Dynamic muscle paralytic effects of a novel botulinum toxin A free of neurotoxin-associated proteins.
Liu WC, Su JH, Feng Y, Xiang XR, Pan LZ, Liu Y, Ma L, Nie ZY, Zhang XP, Jin LJ.
Pharmacol Res Perspect. 2022 Jun;10(3):e00955. doi: 10.1002/prp2.955.
Mammalian neurotoxins, Blarina paralytic peptides, cause hyperpolarization of human T-type Ca channel hCa(v)3.2 activation.
Yano Y, Fukuoka R, Maturana AD, Ohdachi SD, Kita M.
J Biol Chem. 2023 Sep;299(9):105066. doi: 10.1016/j.jbc.2023.105066. Epub 2023 Jul 17.
Dose-Effect Relationship of Botulinum Toxin Type A in the Management of Strabismus: A Review.
Alhejaili AL, Alkayyal AA, Alawaz RA, Alshareef EK, Al-Habboubi H.
Cureus. 2024 Oct 11;16(10):e71271. doi: 10.7759/cureus.71271. eCollection 2024 Oct.
Hypokalemic Periodic Paralysis.
Weber F, Lehmann-Horn F.
2002 Apr 30 [updated 2018 Jul 26]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Outbreaks of paralytic poliomyelitis, 1976-1995.
Patriarca PA, Sutter RW, Oostvogel PM.
J Infect Dis. 1997 Feb;175 Suppl 1:S165-72. doi: 10.1093/infdis/175.supplement_1.s165.
Study of the pathogenesis of paralytic ileus in animal models of experimentally induced postoperative and septic ileus.
De Winter BY.
Verh K Acad Geneeskd Belg. 2003;65(5):293-324.
GLP-1 Receptor Agonists and Risk of Paralytic Ileus: A drug-target Mendelian Randomization Study.
Ding P, Gao Z, Gorenflo MP, Xu R.
medRxiv [Preprint]. 2024 Oct 17:2024.10.17.24315627. doi: 10.1101/2024.10.17.24315627.
Effect of paralytic type on time to post-intubation sedative use in the emergency department.
Watt JM, Amini A, Traylor BR, Amini R, Sakles JC, Patanwala AE.
Emerg Med J. 2013 Nov;30(11):893-5. doi: 10.1136/emermed-2012-201812. Epub 2012 Nov 8.
Intestinal obstruction.
COLE WH.
Calif Med. 1950 Nov;73(5):384-90.
Neurotoxic marine poisoning.
Isbister GK, Kiernan MC.
Lancet Neurol. 2005 Apr;4(4):219-28. doi: 10.1016/S1474-4422(05)70041-7.
